Sacituzumab govitecan in triple-negative breast cancer.

Ann Transl Med

Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Institut national de la santé et de la recherche médicale (INSERM) UMR1068, Centre national de la recherche scientifique (CNRS) UMR725, Equipe labellisée Ligue Nationale Contre Le Cancer, Marseille, France.

Published: June 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263779PMC
http://dx.doi.org/10.21037/atm-22-813DOI Listing

Publication Analysis

Top Keywords

sacituzumab govitecan
4
govitecan triple-negative
4
triple-negative breast
4
breast cancer
4
sacituzumab
1
triple-negative
1
breast
1
cancer
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!